Overview

Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder

Status:
Completed

Trial end date:
2013-09-01

Target enrollment:

Participant gender:

Summary

Phase II Trial of concurrent administration of intravesical BCG & Interferon in the treatment and prevention of recurrence of superficial transitional carcinoma of the urinary bladder.

Phase:

N/A

Details

Lead Sponsor:

King Faisal Specialist Hospital & Research Center

Treatments:

Interferons